2 results
Approved WMOCompleted
The objective of this clinical investigation is to evaluate the short-term clinical feasibility of Vega HP and explore its limitations and advantages. As a result of the evaluations, design changes may be implemented and evaluated until the optimal…
Approved WMOCompleted
The purpose of this study is to investigate how well a new dosage form of tildrakizumab is tolerated when it is administered to healthy volunteers. Tildrakizumab (also known as Ilumetri) is no new compound; it is already available on the market as a…